Lv41
540 积分 2025-08-12 加入
Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulation
3个月前
已完结
An innovative antibody fusion protein targeting PD-L1, VEGF and TGF-β with enhanced antitumor efficacies
3个月前
已完结
A guide to antigen processing and presentation
3个月前
已完结
Nanobody-based drug delivery systems for cancer therapy
4个月前
已完结
LBA11 A phase II clinical study of dose optimization for ZG006 (Alveltamig) in patients with advanced small cell lung cancer who have received at least two prior lines of therapy (ZG006-002)
4个月前
已完结
An innovative antibody fusion protein targeting PD-L1, VEGF and TGF-β with enhanced antitumor efficacies
4个月前
已完结
A Novel CD3/BCMA Bispecific T-cell Redirecting Antibody for the Treatment of Multiple Myeloma
4个月前
已完结
Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulation
4个月前
已完结
Hyper-CVAD and sequential blinatumomab for newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: a single-arm, single-centre, phase 2 trial
4个月前
已完结
Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulation
6个月前
已完结
皖公网安备34019202002308
